About Transpact
Transpact is a company based in Mumbai (India) founded in 2013 by Sudhir Bania. Transpact has raised $225.54 thousand across 3 funding rounds from investors including Aryaman Financial Services, Octaware Technologies and unknown. Transpact offers products and services including Vestibulator and Rehabsoft. Transpact operates in a competitive market with competitors including Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
- Headquarter Mumbai, India
- Founders Sudhir Bania
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Transpact Enterprises Limited
- Date of Incorporation 12 May, 2013
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$21.23 K (USD)236.95as on Mar 31, 2022
-
Net Profit
-$26.72 K (USD)-244.22as on Mar 31, 2022
-
EBITDA
-$25.14 K (USD)-324.71as on Mar 31, 2022
-
Total Equity Funding
$225.54 K (USD)
in 3 rounds
-
Latest Funding Round
$188.3 K (USD), Seed
Aug 31, 2019
-
Investors
Aryaman Financial Services
& 125 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Transpact
Transpact offers a comprehensive portfolio of products and services, including Vestibulator and Rehabsoft.
Device for vestibular rehabilitation and sensory integration therapy.
Cloud-based platform for rehabilitation services and analytics.
Funding Insights of Transpact
Transpact has successfully raised a total of $225.54K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $188.3 thousand completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $188,300
-
First Round
First Round
(14 Nov 2015)
- Investors Count 126
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Seed - Transpact | Valuation | Mukesh Babulal Shah , Mukesh Babulal Shah | |
| Feb, 2016 | Amount | Seed - Transpact | Valuation | Adam Mahmood Thakur , Adam Mahmood Thakur | |
| Nov, 2015 | Amount | Seed - Transpact | Valuation | Octaware Technologies , Sultan Abdul Kader |
Investors in Transpact
Transpact has secured backing from 126 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Aryaman Financial Services, Octaware Technologies and unknown.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
|
Founded Year | Domain | Location | |
|
Investment banking services are provided to lower and mid-market companies.
|
Founded Year | Domain | Location | |
|
IT services suite solutions are provided by Octaware Technologies.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Transpact
Financial Statements - Transpact
Transpact Comparisons
Competitors of Transpact
Transpact operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, Nexstim, MindMaze, Precision Neuroscience and Synergia Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for neurological therapies are developed.
|
|
| domain | founded_year | HQ Location |
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
|
|
| domain | founded_year | HQ Location |
Evidence-based digital neurotherapeutics are developed for brain health recovery.
|
|
| domain | founded_year | HQ Location |
Brain-computer interfaces developed for medical treatment and drug development.
|
|
| domain | founded_year | HQ Location |
Implantable neurostimulators and contactless monitoring systems are developed.
|
|
| domain | founded_year | HQ Location |
Bioelectronic devices are developed for regenerative medicine therapies.
|
Frequently Asked Questions about Transpact
Transpact was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Transpact is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Transpact is a funded company, having raised a total of $225.54K across 3 funding rounds to date. The company's 1st funding round was a Seed of $22.67K, raised on Nov 14, 2015.
Annual revenue of Transpact is $21.23K as on Mar 31, 2022.
Developer of a therapeutic device to stimulate the vestibular system. The companys products include a Vestibulator Chair a therapy device for at-home therapy of children suffering from vestibular dysfunction and developmental disorders, and Vestibulator provides stimulations for neuro-developmental and sensory integration therapy. Also, it offers cloud-based therapy and rehabilitation software solutions.
Transpact's top competitors include Blackrock Neurotech, Precision Neuroscience and Nexstim.
Transpact offers Vestibulator and Rehabsoft.
Transpact has 126 investors. Key investors include Aryaman Financial Services, Octaware Technologies, unknown, Mukesh Babulal Shah, and Aarifa Abdul Gafoor Baig.
The valuation of Transpact is $700.78K as of Aug 2019.